Osaka, Japan

Mari Kaneda

This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Osaka University. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mari Kaneda. Retrieved from https://idiyas.com/inventor/mari-kaneda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mari Kaneda: Innovator in Medical Treatments

Introduction

Mari Kaneda is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of medicine, particularly in the development of treatments for complex medical conditions. Her innovative work has garnered attention and respect within the scientific community.

Latest Patents

One of her notable patents is for an external medicine designed for diffuse plexiform neurofibroma. This invention provides a novel approach to treating this challenging condition. The external medicine contains, as an active ingredient, at least one selected from the group consisting of sirolimus and sirolimus derivatives. This patent highlights her commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Mari Kaneda is affiliated with Osaka University, where she conducts her research and development work. Her role at the university allows her to collaborate with other experts in the field and contribute to groundbreaking research. With 1 patent to her name, she has established herself as a key figure in medical innovation.

Collaborations

One of her notable collaborators is Ichiro Katayama. Together, they work on various projects aimed at enhancing medical treatments and exploring new avenues for research.

Conclusion

Mari Kaneda's contributions to medical innovation, particularly in the treatment of diffuse plexiform neurofibroma, showcase her dedication to improving healthcare. Her work at Osaka University and her collaborations with fellow researchers further emphasize her impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…